“Worcester has a once in a generation opportunity to establish itself as a global #BiomanufacturingHub. Located less than an hour west of #Boston, the region has become a magnet for top #talent, has #land available, can offer a #lowercost of doing business, and is home to a multitude of #highereducation and #hospital institutions to support the #industry. Massachusetts is the global leader in #biotechnology #researchanddevelopment. Now is the time to capture the emerging #biomanufacturing market in the Central part of the state.” – Jon Weaver, President & CEO, MBI. MBI has just released a Regional Biomanufacturing Strategy which calls upon the Commonwealth to designate #CentralMA as a #BiomanufacturingHub and outlines specific programs and strategies that will allow Central MA to successfully compete for this emerging #industry. Thank you to the Boston Business Journal for covering our release. Read the full release at: https://lnkd.in/eB9Wyi8D
Massachusetts Biomedical Initiatives (MBI)
Biotechnology Research
Worcester, Massachusetts 3,953 followers
Advancing Startups from Concept to Clinical Trials
About us
MBI supports early stage startups from Concept to Clinical Trials by offering flexible, private labs as a service. Our team offsets your early headcount and helps nurture your company through to clinical trials so you can get the data you need to secure investment and bring products to patients. MBI is also a leader in workforce and economic development for Central Massachusetts.
- Website
-
https://MBI.bio
External link for Massachusetts Biomedical Initiatives (MBI)
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Worcester, Massachusetts
- Type
- Nonprofit
- Founded
- 1984
- Specialties
- StartUps, ScaleUp, Biotech, Biomanufacturing, Venture Capital, Private Labs, and Biotech Incubator
Locations
-
Primary
17 Briden St
Worcester, Massachusetts 01605, US
-
60 Prescott Street
Worcester, MA 01605, US
-
100 Barber Ave
Worcester, MA 01606, US
Employees at Massachusetts Biomedical Initiatives (MBI)
-
Charles Kunsch
Investor, Biotech builder, Board Member, Life science advisor
-
Chris Palatucci, PhD
Recruiting the world's top life sciences talent
-
Joe Doherty
Jeffrey R. Jay Accounting & Finance Chair at Saint John’s High School | Board Member | Former Division President
-
Raymond Knox
Founder & Principal Consultant, KBDG
Updates
-
Massachusetts Biomedical Initiatives (MBI) reposted this
So much great support available from NCI #SBIR! Don't miss out.
Director of the Small Business Innovation Research Development Center at NCI SBIR Development Center
NCI #SBIR is proud to have pioneered initiatives like the Applicant Assistance Program (AAP), started in 2017 by NCI SBIR program directors to support applicants with no prior experience writing an NIH SBIR/STTR application. Over the years, AAP has grown to provide free Phase I SBIR/STTR application coaching to hundreds of companies across 10 NIH institutes. Read the recent publication on AAP in Nature to learn how the program has worked to enrich the SBIR/STTR awardee pool and improve access to non-dilutive funds by helping participants develop more competitive applications: https://lnkd.in/dYNdVBD6
NIH Applicant Assistance Program counteracts decades of underrepresentation in SBIR grant awardees - Nature Biotechnology
nature.com
-
Congratulations to #MBIgraduate Invetx on being acquired by Dechra Pharmaceuticals! We are always so happy to see our #startups' hard work and dedication to their science pay off! #congratulations #startupsuccess #acquired #aquisition #veterinaryscience #therapeutics #monoclonalantibody
We are thrilled to announce that Invetx has agreed to be acquired by Dechra Pharmaceuticals, a global leader in animal health, for up to $520 million on a cash-free and debt-free basis. Our pipeline of monoclonal antibody therapeutics for companion animals and our species-specific, half-life extension technology platform will complement and differentiate Dechra’s broad portfolio of specialty therapeutics for companion animals. We want to thank our numerous veterinary collaborators and their canine and feline patients, technology partners, investors and consultants who have helped create the value at Invetx leading to this important inflection point. The acquisition remains subject to antitrust approval and other customary closing conditions. https://lnkd.in/gWZgvhnM #veterinarybiotherapeutics #companionanimals #animalhealth
-
ICYMI, yesterday in our MBI #newsletter, we not only highlighted our Regional Biomanufacturing Strategy, but also released the second of our #40for40 stories! This story puts a spotlight on our #workforcedevelopment group, the Biomanufacturing Workforce Initiative that we created with the help of MassHire. Our group has grown to over 30 groups representing #industry and #academia. Read the story today and if you haven't already, sign up for our newsletters so you don't miss a thing: https://lnkd.in/eRh_Bi7m #MBI40for40 #stories #STEM #startups #workforce #coalition #partnerships #teamworkmakesthedreamwork
BRIDGING THE GAP: THE BIOMANUFACTURING WORKFORCE INITIATIVE
mbi.bio
-
Massachusetts Biomedical Initiatives (MBI) reposted this
Massachusetts Biomedical Initiatives (MBI) is calling on state officials to designate Central Massachusetts as a Biomanufacturing Hub and invest in the region to help it compete in this growing industry.
Report makes case for Central Mass. as a biomanufacturing hub
-
Massachusetts Biomedical Initiatives (MBI) reposted this
We are honored to be a part of the 2024 MassChallenge U.S. Early Stage Cohort, among 128 entrepreneurs to have been chosen. We are grateful for the opportunity to be recognized among such incredible companies, and to have been selected from 1300 applicants. This accelerator program will provide entrepreneurial training, exposure to partners and investors, and much more. Thank you MassChallenge, and congratulations to all of the other #startups who were selected. #MC24 #earlystagestartups #entrpreneur #ClimateTech
📣 Announcing the NEW 2024 MassChallenge U.S. Early Stage Cohort: We have invited 128 #startups to participate in the 2024 U.S. Early Stage Program. Meet the Founders 🤝 https://hubs.li/Q02GftwD0 🎉 These #Founders were selected out of 1,300 applications 👏 Experienced #Judges in the MassChallenge community contributed to 2 rigorous rounds of evaluation 💰 The 2024 U.S. Early Stage cohort features startups from pre-revenue companies, to those with millions in lifetime revenue The founders will benefit from: 🤝 Unrivaled access to 40+ global corporate partners including BAE Systems, Mitsubishi Corporation, International Space Station National Laboratory, and more 🥇 World-class mentoring from 400+ industry experts with tailored, evidence-based curriculum ✈️ Market Access: Founders will be flown to get connected into MassChallenge's global network 💰 Opportunities to compete for cash prizes + in-kind awards Congratulations everyone! #MC24 Spread the good news! 👍 #earlystagestartups #accelerators #startupsuccess Jessica Davis David Meyer Robby Bitting Ernesto C. Martinez-Villalpando, Ph.D. Will Magruder Gaurav Manchanda
-
Congratulations to MBI resident startup Codomax on securing their third Phase 1 #STTR grant! Codomax exemplifies the success of MBI companies in consistently securing multiple #grants for funding! #STEM #startupsuccess #NIH #SBIR #STTR #grants #incubator #support The National Institutes of Health National Center for Advancing Translational Sciences (NCATS) #biomanufacturing
We are excited to announce that Codomax has been awarded a third Phase I STTR grant from the NIH's National Center for Advancing Translational Sciences (NCATS). Our project, Designer Pichia Strains that Enable Difficult-to-Express Biologics Production by Addressing Limitations in Secretory Protein Expression, is a collaboration between Codomax (led by PI Dr. Shane Byrne) and The Johns Hopkins University (led by PI Prof. Stephen Fried). The Fried lab has developed mass spectrometry-based structural proteomics methods to characterize protein folding of secreted and intracellular proteins. Together Codomax and the Fried Lab will combine their respective strengths in omics, tRNA biology, Pichia strain engineering, and structural proteomics to engineer Pichia strains that improve assembly and folding of recombinant proteins. Efforts to increase biomanufacturing efficiency have largely focused on translational optimization to increase protein yields. However, some protein remain difficult-to-express not only due to challenges in mRNA translation, but also due to impaired polypeptide assembly and transport through the secretory pathway. While Pichia pastoris yeast remains a popular and effective biomanufacturing host organism, further strain improvements are needed to enable high-yielding production of difficult-to-express products. Here, we leverage the Epi-MAX platform's tRNA-centric strain engineering approach to engineer secretory pathway chaperones in Pichia to enable high yielding production of difficult-to-express biologics. These new Pichia strains will be engineered to leverage cellular stress response mechanisms and translational reprogramming to increase production efficiency of properly folded and efficiently translated secreted proteins. More information available at: https://lnkd.in/ePSxJVCi
RePORT 〉 RePORTER
reporter.nih.gov
-
You probably know by now that MBI is a nonprofit focused on building the #CentralMABioCluster... but do you know the origin story of MBI? We bet you don't! To celebrate MBI's #40thAnniversary, we invite you to discover short stories that highlight MBI's 40-year journey and celebrate our rich history, impactful work, and the innovative spirit that has shaped the life sciences landscape in Central MA. Check out this post about MBI's beginnings and stay tuned as we post more #40for40 stories over the next few months! #anniversary #STEM #startup #incubator #CentralMABioCluster #nonprofit #40years #milestone #origins https://lnkd.in/eUN8suHc
MBI: Catalyst of Innovation - 40 for 40
mbi.bio
-
Massachusetts Biomedical Initiatives (MBI) reposted this
Join us for our first Summer Block Party in partnership with Massachusetts Biomedical Initiatives (MBI) at their facility in Worcester, MA on Wednesday, July 31! Let's celebrate the vibrant community of women in bio and women entrepreneurs of Worcester together. Tour the MBI facilities, explore a variety of booths, connect with business owners, and visit food trucks. Register today at https://lnkd.in/eapmYkgq Vendors include: 🎂Bri's Sweet Treats - https://lnkd.in/e-U5SYAh 📿Trinity Silver Jewelry - https://lnkd.in/eYVsagjJ 🔗Forever Linked Permanent Jewelry - https://lnkd.in/eJNzEsf6 👝SpadXTech Vegan Leather Goods 🐷Iron Hog BBQ 🍧Kona Ice 🕯K Sense Co Candles - https://ksenseco.com/ More to come! Thank you to our sponsor Bothwell Engineering Inc.! If you're interested in sponsoring this event, please reach out to [email protected]. Date: Wednesday, July 31, 2024 Time: 4:30 p.m. - 8:00 p.m. Location: 17 Briden St, Worcester, MA 01605 Cost: Members FREE, Non-Members $15